Healthcare provider profile · identity verified

Dean Petrucci

Internal Medicine · HERMITAGE, PA · NPI 1831164003

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	661	151
Atorvastatin Calcium	Atorvastatin Calcium	507	120
Omeprazole	Omeprazole	420	104
Amlodipine Besylate	Amlodipine Besylate	354	84
Lisinopril	Lisinopril	320	79
Metoprolol Succinate	Metoprolol Succinate	315	78
Pantoprazole Sodium	Pantoprazole Sodium	311	81
Potassium Chloride	Potassium Chloride	302	67
Gabapentin	Gabapentin	269	66
Prednisone	Prednisone	263	159
Rosuvastatin Calcium	Rosuvastatin Calcium	256	64
Pravastatin Sodium	Pravastatin Sodium	234	61
Tamsulosin Hcl	Tamsulosin Hcl	234	56
Metformin Hcl	Metformin Hcl	224	58
Fluticasone Propionate	Fluticasone Propionate	195	69
Alendronate Sodium	Alendronate Sodium	176	39
Eliquis	Apixaban	174	28
Metoprolol Tartrate	Metoprolol Tartrate	174	39
Losartan Potassium	Losartan Potassium	172	46
Albuterol Sulfate Hfa	Albuterol Sulfate	166	39
Furosemide	Furosemide	155	50
Duloxetine Hcl	Duloxetine Hcl	152	31
Jardiance	Empagliflozin	149	37
Sertraline Hcl	Sertraline Hcl	143	34
Allopurinol	Allopurinol	124	34
Hydrochlorothiazide	Hydrochlorothiazide	119	30
Mirtazapine	Mirtazapine	112	27
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	110	27
Glipizide	Glipizide	108	27
Escitalopram Oxalate	Escitalopram Oxalate	107	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	101	80
Clopidogrel	Clopidogrel Bisulfate	96	27
Meloxicam	Meloxicam	95	26
Oxybutynin Chloride Er	Oxybutynin Chloride	95	24
Carvedilol	Carvedilol	94	21
Ozempic	Semaglutide	94	15
Irbesartan	Irbesartan	90	19
Alprazolam	Alprazolam	89	16
Citalopram Hbr	Citalopram Hydrobromide	87	21
Warfarin Sodium	Warfarin Sodium	85	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	83	20
Famotidine	Famotidine	82	23
Finasteride	Finasteride	81	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	20
Atenolol	Atenolol	77	21
Diclofenac Sodium	Diclofenac Sodium	75	20
Baclofen	Baclofen	72	24
Simvastatin	Simvastatin	70	16
Donepezil Hcl	Donepezil Hcl	68	20
Synthroid	Levothyroxine Sodium	67	17
Ventolin Hfa	Albuterol Sulfate	65	16
Buspirone Hcl	Buspirone Hcl	64	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	62	18
Sucralfate	Sucralfate	62	15
Triamcinolone Acetonide	Triamcinolone Acetonide	62	29
Venlafaxine Hcl Er	Venlafaxine Hcl	60	suppressed
Trulicity	Dulaglutide	58	suppressed
Enalapril Maleate	Enalapril Maleate	54	14
Dicyclomine Hcl	Dicyclomine Hcl	53	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	11
Xarelto	Rivaroxaban	51	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	36
Hydroxyzine Hcl	Hydroxyzine Hcl	48	17
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	22
Fenofibrate	Fenofibrate Nanocrystallized	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	suppressed
Farxiga	Dapagliflozin Propanediol	41	suppressed
Nystatin	Nystatin	40	26
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Bumetanide	Bumetanide	39	suppressed
Memantine Hcl	Memantine Hcl	39	suppressed
Bupropion Hcl Sr	Bupropion Hcl	38	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	28
Pregabalin	Pregabalin	38	suppressed
Lorazepam	Lorazepam	37	suppressed
Colestipol Hcl	Colestipol Hcl	36	suppressed
Ibandronate Sodium	Ibandronate Sodium	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Ipratropium Bromide	Ipratropium Bromide	34	13
Meclizine Hcl	Meclizine Hcl	34	17
Trazodone Hcl	Trazodone Hcl	34	suppressed
Clonazepam	Clonazepam	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	28
Tolterodine Tartrate Er	Tolterodine Tartrate	31	suppressed
Celecoxib	Celecoxib	29	suppressed
Fenofibrate	Fenofibrate,micronized	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Tiotropium Bromide	Tiotropium Bromide	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Nitroglycerin	Nitroglycerin	28	14
Glipizide Er	Glipizide	27	suppressed
Fluconazole	Fluconazole	26	15
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Topiramate	Topiramate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Dapagliflozin	Dapagliflozin Propanediol	19	suppressed
Felodipine Er	Felodipine	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Temazepam	Temazepam	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	16
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Naproxen	Naproxen	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Amoxicillin	Amoxicillin	16	12
Myrbetriq	Mirabegron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Cephalexin	Cephalexin	15	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Icosapent Ethyl	Icosapent Ethyl	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Cimetidine	Cimetidine	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Torsemide	Torsemide	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error